Harbour Biomed

Developer of antibody therapeutics in immunology and oncology disease

placeShanghai, Shanghai, China calendar_todayFounded 2016 groups167 employees language harbourbiomed.com

Social engagement

Social engagement: 6.3K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

21 investors on record; lead investors include ZSVC, Zhejiang University, GIC, SK.

Investor typeCountShare
Venture capital943%
Private equity524%
Other / undisclosed733%

Recent activity

15 Jun 2026
Partnership
BioMap
12 Jun 2026
Leadership hire
Scientific Advisor
11 Jun 2026
Leadership hire
Scientific Advisor
Coming soon